These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1155983)
61. Effect of coenzyme Q on serum levels of creatine phosphokinase in preclinical muscular dystrophy. Folkers K; Nakamura R; Littarru GP; Zellweger H; Brunkhorst JB; Williams CW; Langston JH Proc Natl Acad Sci U S A; 1974 May; 71(5):2098-102. PubMed ID: 4525474 [TBL] [Abstract][Full Text] [Related]
62. Effect of limb restraints on serum creatine phosphokinase activity in normal volunteers. Goode DJ; Weinberg DH; Mazura TA; Curtiss G; Moretti RJ; Meltzer HY Biol Psychiatry; 1977 Dec; 12(6):743-55. PubMed ID: 597527 [TBL] [Abstract][Full Text] [Related]
63. MB-creatine phosphokinase isoenzyme elevation not diagnostic of myocardial infarction. Adornato BT; Engel WK Arch Intern Med; 1977 Aug; 137(8):1089-90. PubMed ID: 879953 [No Abstract] [Full Text] [Related]
64. [Assessment of the results of serum enzyme studies in different forms of myocardial infarction]. Tokarskaia ZB; Okladnikova ND; Surina AG Kardiologiia; 1983 Jul; 23(7):64-9. PubMed ID: 6620815 [TBL] [Abstract][Full Text] [Related]
66. Mean serum creatine kinase activity in patients with functional psychoses. Meltzer HY; Ross-Stanton J; Schlessinger S Arch Gen Psychiatry; 1980 Jun; 37(6):650-5. PubMed ID: 7387337 [TBL] [Abstract][Full Text] [Related]
67. Serum creatine phosphokinase as predictor of intermediate syndrome in organophosphorus poisoning. Kumar GC; Bhuvana K; Venkatarathnamma PN; Sarala N Indian J Crit Care Med; 2015 Jul; 19(7):384-7. PubMed ID: 26180430 [TBL] [Abstract][Full Text] [Related]
68. [The evaluation of serum creatine phosphokinase for estimation of energy expenditure in human subjects]. Imaki M; Miyoshi T; Matsumoto K; Murai Y; Oogimoto S; Sei M Sangyo Igaku; 1991 Sep; 33(5):403-9. PubMed ID: 1753445 [TBL] [Abstract][Full Text] [Related]
69. Spondylometry in a normal population and in ankylosing spondylitis. Sturrock RD; Wojtulewski JA; Hart FD Rheumatol Rehabil; 1973 Aug; 12(3):135-42. PubMed ID: 4741429 [No Abstract] [Full Text] [Related]
70. Observations on plasma creatine phosphokinase activity in dogs. Heffron JJ; Bomzon L; Pattinson RA Vet Rec; 1976 Apr; 98(17):338-40. PubMed ID: 936429 [TBL] [Abstract][Full Text] [Related]
71. Serum creatine phosphokinase in amyotrophic lateral sclerosis. Correlation with sex, duration, and skeletal muscle biopsy. Amrit AN; Anderson MS Neurology; 1974 Sep; 24(9):834-7. PubMed ID: 4859480 [No Abstract] [Full Text] [Related]
75. Normal range of spinal mobility. An objective clinical study. Moll JM; Wright V Ann Rheum Dis; 1971 Jul; 30(4):381-6. PubMed ID: 5557779 [No Abstract] [Full Text] [Related]
76. Normal ranges for serum creatine phosphokinase. Miyada DS; Nakamura RM; Boyko L Clin Chem; 1972 Feb; 18(2):171-3. PubMed ID: 5008528 [No Abstract] [Full Text] [Related]
77. Plasma creatine phosphokinase in schizophrenia. Kondaiah P; Murthy KK; Reddi OS Indian J Psychiatry; 1981 Oct; 23(4):351-2. PubMed ID: 22058561 [TBL] [Abstract][Full Text] [Related]
78. Letter: Interpretation of CPK activity. Meltzer HY JAMA; 1974 Aug; 229(9):1169. PubMed ID: 4407929 [No Abstract] [Full Text] [Related]
79. Testing the Validity of the Diamond Steps Test for Balance in Healthy Adults. Shao S; Maruyama H Arch Rehabil Res Clin Transl; 2020 Dec; 2(4):100091. PubMed ID: 33543113 [TBL] [Abstract][Full Text] [Related]
80. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study. Landewé R; Braun J; Deodhar A; Dougados M; Maksymowych WP; Mease PJ; Reveille JD; Rudwaleit M; van der Heijde D; Stach C; Hoepken B; Fichtner A; Coteur G; de Longueville M; Sieper J Ann Rheum Dis; 2014 Jan; 73(1):39-47. PubMed ID: 24013647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]